title: Retinopathy in diabetes.
authors.forename: Donald S
authors.initials: DS
authors.lastname: Fong
authors.forename: Lloyd
authors.initials: L
authors.lastname: Aiello
authors.forename: Thomas W
authors.initials: TW
authors.lastname: Gardner
authors.forename: George L
authors.initials: GL
authors.lastname: King
authors.forename: George
authors.initials: G
authors.lastname: Blankenship
authors.forename: Jerry D
authors.initials: JD
authors.lastname: Cavallerano
authors.forename: Fredrick L
authors.initials: FL
authors.lastname: Ferris
authors.forename: Ronald
authors.initials: R
authors.lastname: Klein
mesh_terms: D001241:Aspirin / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology; D003930:Diabetic Retinopathy / Q000503:physiopathology / Q000517:prevention & control* / Q000601:surgery / Q000628:therapy; D006801:Humans; D017075:Laser Coagulation / Q000592:standards; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011785:Quality Assurance, Health Care
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin